1
2
Toorop, Myrthe M.A., Chen, Qingui, Tichelaar, Vladimir Y.I.G., Cannegieter, Suzanne C., Lijfering, Willem M.
Veröffentlicht in: Toorop , M M A , Chen , Q , Tichelaar , V Y I G , Cannegieter , S C & Lijfering , W M 2021 , ' Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation : A Dutch Nationwide Cohort Study ' , European Heart Journal , vol. 42 , no. 40 , pp. 4126-4137 . https://doi.org/10.1093/eurheartj/ehab421;
2021
Veröffentlicht in: Toorop , M M A , Chen , Q , Tichelaar , V Y I G , Cannegieter , S C & Lijfering , W M 2021 , ' Predictors, time course, and outcomes of persistence patterns in oral anticoagulation for non-valvular atrial fibrillation : A Dutch Nationwide Cohort Study ' , European Heart Journal , vol. 42 , no. 40 , pp. 4126-4137 . https://doi.org/10.1093/eurheartj/ehab421;
2021
3
4
Catharina CM Kager, Maaike Horsselenberg, Joke C Korevaar, Cordula Wagner, Karin Hek
Veröffentlicht in: BJGP Open, Vol 7, Iss 1 (2023);
2023
Veröffentlicht in: BJGP Open, Vol 7, Iss 1 (2023);
2023
5
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017